231 related articles for article (PubMed ID: 8228262)
1. Exacerbation of murine herpes simplex virus-mediated stromal keratitis by Th2 type T cells.
Jayaraman S; Heiligenhaus A; Rodriguez A; Soukiasian S; Dorf ME; Foster CS
J Immunol; 1993 Nov; 151(10):5777-89. PubMed ID: 8228262
[TBL] [Abstract][Full Text] [Related]
2. [Glycoprotein D (5-23) specific Th2-T-cell line induces HSV-1 keratitis].
Heiligenhaus A; Jayaraman S; Soukiasian S; Dorf M; Foster CS
Ophthalmologe; 1995 Aug; 92(4):484-91. PubMed ID: 7549333
[TBL] [Abstract][Full Text] [Related]
3. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288
[TBL] [Abstract][Full Text] [Related]
4. Murine herpes simplex virus keratitis is accentuated by CD4+, V beta 8.2+ Th2 T cells.
Foster CS; Rodriguez Garcia A; Pedroza-Seres M; Berra A; Heiligenhaus A; Soukiasian S; Jayaraman S
Trans Am Ophthalmol Soc; 1993; 91():325-48; discussion 349-50. PubMed ID: 7908153
[No Abstract] [Full Text] [Related]
5. Immunopathology of herpetic stromal keratitis: discordance in CD4+ T cell function between euthymic host and reconstituted SCID recipients.
Thomas J; Rouse BT
J Immunol; 1998 Apr; 160(8):3965-70. PubMed ID: 9558104
[TBL] [Abstract][Full Text] [Related]
6. Herpetic stromal keratitis: an immunopathologic disease mediated by CD4+ T lymphocytes.
Doymaz MZ; Rouse BT
Invest Ophthalmol Vis Sci; 1992 Jun; 33(7):2165-73. PubMed ID: 1351475
[TBL] [Abstract][Full Text] [Related]
7. Restricted T cell receptor beta-chain variable region protein use by cornea-derived CD4+ and CD8+ herpes simplex virus-specific T cells in patients with herpetic stromal keratitis.
Maertzdorf J; Verjans GM; Remeijer L; van der Kooi A; Osterhaus AD
J Infect Dis; 2003 Feb; 187(4):550-8. PubMed ID: 12599071
[TBL] [Abstract][Full Text] [Related]
8. [T-cell-induced prevention of HSV-1 keratitis by immunization with the synthetic peptide of glycoprotein D].
Heiligenhaus A; Berra A; Dutt JE; Zhao TZ; Wells PA; Foster CS
Ophthalmologe; 1994 Oct; 91(5):608-16. PubMed ID: 7812092
[TBL] [Abstract][Full Text] [Related]
9. Amniotic membrane transplantation induces apoptosis in T lymphocytes in murine corneas with experimental herpetic stromal keratitis.
Bauer D; Wasmuth S; Hennig M; Baehler H; Steuhl KP; Heiligenhaus A
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3188-98. PubMed ID: 19255156
[TBL] [Abstract][Full Text] [Related]
10. Analysis of T cell receptor V beta gene expression in B cell deficient mice after experimental herpes simplex virus keratitis.
Arrunategui-Correa V; Dutt JE; Foster CS
Acta Virol; 1997 Jun; 41(3):145-52. PubMed ID: 9385402
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus-specific T cells infiltrate the cornea of patients with herpetic stromal keratitis: no evidence for autoreactive T cells.
Verjans GM; Remeijer L; Mooy CM; Osterhaus AD
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2607-12. PubMed ID: 10937573
[TBL] [Abstract][Full Text] [Related]
12. Virus-induced immunoinflammatory lesions in the absence of viral antigen recognition.
Gangappa S; Babu JS; Thomas J; Daheshia M; Rouse BT
J Immunol; 1998 Oct; 161(8):4289-300. PubMed ID: 9780205
[TBL] [Abstract][Full Text] [Related]
13. Antibody-dependent cellular cytotoxicity against cells infected with herpes simplex virus type 1 in Igh-1 disparate congenic mice.
Tamesis RR; Rodriguez A; Hoang-Xuan T; Foster CS
Ger J Ophthalmol; 1993 Aug; 2(4-5):218-23. PubMed ID: 8220102
[TBL] [Abstract][Full Text] [Related]
14. Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis.
Inoue T; Inoue Y; Nakamura T; Yoshida A; Takahashi K; Inoue Y; Shimomura Y; Tano Y; Fujisawa Y; Aono A; Hayashi K
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4209-15. PubMed ID: 11095617
[TBL] [Abstract][Full Text] [Related]
15. Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis.
Banerjee K; Biswas PS; Rouse BT
J Leukoc Biol; 2005 Jan; 77(1):24-32. PubMed ID: 15496448
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge.
Frye TD; Chiou HC; Hull BE; Bigley NJ
Arch Virol; 2002 Sep; 147(9):1747-59. PubMed ID: 12209314
[TBL] [Abstract][Full Text] [Related]
17. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
Ritchie MH; Oakes JE; Lausch RN
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
[TBL] [Abstract][Full Text] [Related]
18. T cell receptor V beta gene expression in experimental herpes stromal keratitis.
Pedroza-Seres M; Goei S; Merayo-Lloves J; Dutt JE; Lee SJ; Arrunategui-Correa V; Foster CS
Eye (Lond); 1995; 9 ( Pt 5)():599-604. PubMed ID: 8543080
[TBL] [Abstract][Full Text] [Related]
19. [Cytokine expression in murine cornea tissue during recurrent herpetic stromal keratitis].
Xia LK; Zhang JS; Chen XL; Wang AY
Zhonghua Yan Ke Za Zhi; 2005 May; 41(5):403-8. PubMed ID: 15938803
[TBL] [Abstract][Full Text] [Related]
20. Immunological aspects of herpetic stromal keratitis.
Inoue Y
Semin Ophthalmol; 2008; 23(4):221-7. PubMed ID: 18584559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
